期刊文献+

1-(1H-1,2,4-三唑-1-基)-(2,4-二氟苯基)-3-取代-2-丙醇类化合物的合成及其抗真菌活性 被引量:4

Synthesis and antifungal activities of 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-[(4-substituted-piperazine)-1-yl]-2-propanols
在线阅读 下载PDF
导出
摘要 目的研究不同取代哌啶和环仲胺侧链的引入对三唑醇类化合物抗真菌活性的影响。方法以氟康唑为先导化合物,设计合成了9个三唑醇类新化合物,化合物的结构均通过核磁、红外光谱确证;选择8种真菌为实验菌株,根据美国国家临床实验室标准委员会(NCCLS)推荐的标准化抗真菌敏感性实验方法,进行体外抑菌活性测试。结果目标化合物对8种真菌特别是深部真菌均有一定的抑制作用,其中化合物4、5对白色念珠菌的MIC80值小于或等于0.125μg.mL-1,是氟康唑活性的4倍以上,与伊曲康唑活性相当。结论立体化学因素的改变对该类化合物体外抑菌活性有较大影响。 Aim To study the effect of the triazole derivatives with the side chain containing (4-substituted- piperidine)-1-yl or second amine on the antifungal activity of triazole compounds. Methods Nine title compounds were synthesized and determined by the elementary analysis, ^1H-NMR and IR spectra. The MICs of all the title compounds were determined by the method recommended by the national committee for clinical laboratory standards(NCCLS)using the RPMI 1640 test medium. Results All of the title compounds displayed potent antifungal activities to some extent. The activity of the two compounds 4, 5 were more than 4 times as high as that of fluconazole and itraconazole against Candida albicans in vitro. Conclusion The stereochemistry has important influence on the antifungal activities of the title compounds.
出处 《中国药物化学杂志》 CAS CSCD 2006年第3期150-153,共4页 Chinese Journal of Medicinal Chemistry
基金 国家自然科学基金项目(30300437)
关键词 药物化学 化合物制备 化学合成 三唑类 哌啶 抗真菌活性 medicinal chemistry compound preparation chemical synthesis triazole compounds piperidine antifungal activity
  • 相关文献

参考文献4

二级参考文献14

  • 1王文莉,王端礼,李世荫,李若瑜,万哲,王晓红.NCCLS方案检测氟康唑对酵母菌的最小抑菌浓度[J].中华皮肤科杂志,1996,29(5):374-376. 被引量:13
  • 2Kurtz N,Newton RE,Temple DL Jr.Use of gepirone for preparing pharmaceutical compositions for alleviation of panic disorders[P].European Patent:No.0301239A2.1988-06-23.
  • 3Sheehan DV.Current concepts in psychiatry:panic attacks and phobias[J].N Engl J Med,1982,307(3):156-158.
  • 4Wilson JH,Taylor PJ,Robertson G.The validity of the SCL-90 in a sample of British men remanded to prison for psychiatric reports[J].Br J Psychiatry,1985,147(3):400-403.
  • 5Temple DL Jr.2-[4-(4,4-dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl pyriminines[P].United States Patent:No.4423049.1983-12-27.
  • 6Boschman CR,Bodnar UR,Tornatore MA,Thirteenyear evolution of azole resistance in yeast isolates and prevalence of resistant strains carried by cancer patient at a large medical center[J].Antimicrob Agents Chemother,1998,42:734-738.
  • 7Maher MB,Steven DL,Pranab KM,et al.Mechanisms of fungal resistance[J].Drugs,2002,62(7):1025-1040.
  • 8Goldani LZ,Mario PS.Candida tropicalis fungemia in a teriary care hospital[J].Journal of Infection,2003,46:155-160.
  • 9Richardson K.Antifungal 1,3-bis-trizolyl-2-propanol derivative[P].GB:209918,1982-12-15.
  • 10刘超美 孙青龚.取代丙基三唑类抗真菌化合物和其盐类以及制备方法[P].中国专利:1324792A.2001-12-05.

共引文献28

同被引文献13

  • 1Nuccil M, Marr KA. Emerging fungal diseases [ J]. Clin. Infect. Dis, 2005, 41 : 521.
  • 2ODDS FC. Resistance of yeasts to azole-derivative antifungals [ J ]. J Antimicrob Chemother, 1993, 31 (4) : 463.
  • 3Zhao QJ, Hu H. G, Li YW, et al. Design, Synthesis, and antifungal activities of novel 1H-triazole derivatives based on the structure of the active site of fungal lanosterol 14a-demethylase ( CYPS1 ) [ J]. Chemistry & Biodiversity, 2007, 4 : 1472.
  • 4Chai XY, Zhang J, Yu SC, et al. Design, synthesis, and biological evaluation of novel 1 -( 1H-1,2,4-tfiazole-1-yl ) -2-( 2,4- difluorophenyl )-3-substituted benzylamino-2-propanols [ J]. Bioorg Med Chem Lett, 2009, 19(6) :1811.
  • 5National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal SusceptibiLity Testing of Yeasts, Approved standard [ J ]. Document M27-A2 [ s ], PA: Wayne : 2002.
  • 6Nuccil M, Marr KA. Emerging fungal diseases[J]. Clin Infect Dis, 2005, 41: 521.
  • 7ODDS FC. Resistance of yeasts to azole-derivative antifungals[J]. J Antimicrob Chemother,1993, 31(4): 46.
  • 8Vanden Bossche H, Koymans L, Cytochromes P450 in fungi[J]. Mycoses, 1998,41: (Suppl. l): 32.
  • 9Zhao QJ, Hu HG, Li Yw, et al. Design, Synthesis, and antifungal activities of novel 1H-triazole derivatives based on the structure of the active site of fungal lanosterol 14a-demethylase(CYP51)[J]. Chemistry &Biodiversity, 2007, 4: 1472.
  • 10Chai XY, Zhang J, Yu SC, et al. Design, synthesis, and biological evaluation of novel 1-(1H-1,2,4-triazole-1-y1)-2-(2,4-difluoropheny1)-3-substituted benzylamino-2-propanols[J]. Bioorg Med Chem Lett, 2009, 19(6): 1811.

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部